StockData
Atea Pharmaceuticals, Inc. logo

Atea Pharmaceuticals, Inc. (AVIR) stock

AVIRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$3.96−0.16 (-3.88%)

Close on Nov 17, 2026Market cap $317.61MP/E –Yield –

Atea Pharmaceuticals total assets

Total assets on the balance sheet at the end of each period.

Atea Pharmaceuticals's total assets was $232.28M at Jun 30, 2026. For fiscal 2025 it was $315.22M, down 32.2% from the year before. The highest annual figure on record is $863.63M in fiscal 2020.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$315.22M-32.2%
FY2024Dec 31, 2024$464.67M-21.9%
FY2023Dec 31, 2023$594.97M-10.8%
FY2022Dec 31, 2022$666.71M-13.7%
FY2021Dec 31, 2021$772.89M-10.5%
FY2020Dec 31, 2020$863.63M+3812.6%
FY2019Dec 31, 2019$22.07M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$232.28M-40.7%
Q1 FY2026Mar 31, 2026$267.08M-39.3%
Q4 FY2025Dec 31, 2025$315.22M-32.2%
Q3 FY2025Sep 30, 2025$342.96M-30.1%
Q2 FY2025Jun 30, 2025$391.61M-23.3%
Q1 FY2025Mar 31, 2025$439.96M-20.4%
Q4 FY2024Dec 31, 2024$464.67M-21.9%
Q3 FY2024Sep 30, 2024$490.96M-19.3%
Q2 FY2024Jun 30, 2024$510.38M-18.5%
Q1 FY2024Mar 31, 2024$553.03M-13.3%
Q4 FY2023Dec 31, 2023$594.97M-10.8%
Q3 FY2023Sep 30, 2023$608.08M-11.4%
Q2 FY2023Jun 30, 2023$626.03M-9.8%
Q1 FY2023Mar 31, 2023$638.13M-11.0%
Q4 FY2022Dec 31, 2022$666.71M-13.7%
Q3 FY2022Sep 30, 2022$686.58M-18.6%
Q2 FY2022Jun 30, 2022$694.34M-20.3%
Q1 FY2022Mar 31, 2022$717.19M-14.7%
Q4 FY2021Dec 31, 2021$772.89M-10.5%
Q3 FY2021Sep 30, 2021$843.50M+666.1%
Q2 FY2021Jun 30, 2021$871.54M+3848.5%
Q1 FY2021Mar 31, 2021$840.65M–
Q4 FY2020Dec 31, 2020$863.63M–
Q3 FY2020Sep 30, 2020$110.11M–
Q4 FY2019Dec 31, 2019$22.07M–

More Atea Pharmaceuticals figures

See a number that looks wrong?